Key Highlights

  • FedEx Freight is trading up 14.61% at $125.72 after its four-month transition period results.
  • Cavco Industries is trading up 14.46% at $626.36 after record fiscal second-quarter Revenue of $656.4 million.
  • Regeneron Pharmaceuticals is trading up 14.21% at $935.14 after third-quarter revenue rose 36% to $5.1 billion.
  • AutoNation is trading up 10.73% at $187.51 with a $1.0 billion buyback authorization added in October.
  • Veralto is trading up 8.97% at $113.39 after raising full-year adjusted Earnings guidance to $4.49 to $4.52 per share.

Which High-Priced Stocks Are Gaining the Most Today?

Five stocks priced above $100 a share are posting the largest percentage gains on Oct 30, 2026, ranked here by size of move. FedEx Freight (NYSE:FDXF) leads, trading up 14.61% at $125.72. Cavco Industries (NASDAQ:CVCO) is trading up 14.46% at $626.36, and Regeneron Pharmaceuticals (NASDAQ:REGN) is trading up 14.21% at $935.14.

AutoNation (NYSE:AN) is trading up 10.73% at $187.51, while Veralto (NYSE:VLTO) is trading up 8.97% at $113.39. Each percentage is measured against that stock's own prior close, so the bases differ and the dollar value of a move varies widely from one name to the next.

All five have published fresh financial results or guidance, which the company disclosures point to as the likeliest backdrop for the gains. The sections below note where valuation figures come from earlier snapshots that predate today's move, and where the link between a report and the price jump rests on timing rather than a stated cause.

1. FedEx Freight: why is the stock trading higher after its first standalone report?

FedEx Freight shares are trading up 14.61% at $125.72 after the company reported results for a one-time four-month transition period from June 1 to September 30, 2026. It is the first report since the spin-off from FedEx (NYSE:FDX). Revenue was $3.3 billion, up 9.2%, helped by fuel surcharges, heavier shipments, an extra operating day and firmer base pricing, while average daily shipments slipped 1.4%.

Adjusted Operating Income rose 16.4% to $510 million, a 15.5% margin, though GAAP Diluted Earnings per Share fell 43% to $1.54 as $127 million of spin-off costs weighed. Management raised adjusted operating income guidance for the period through Dec 31, 2026 to $695 million to $715 million, up from $605 million to $645 million.

The Business is North America's largest less-than-truckload carrier. Market data showing a Market Value near $18.7 billion and a 52-week range of $103.48 to $200.00 may be partly post-move, so those figures are approximate.

2. Cavco Industries: what is behind the jump after record quarterly revenue?

Cavco shares are trading up 14.46% at $626.36 after the Phoenix-based manufactured home builder reported fiscal second-quarter results for the period ended Sept 26, 2026. Revenue rose about 18% to $656.4 million and homes sold climbed about 15% to 5,972. Diluted earnings were $7.17 per share against $6.55, although a one-time $7 million insurance premium refund contributed roughly $0.70.

Gross Margin narrowed to 22.5% from 24.2% on higher input costs, yet Backlog reached $348 million, up $50 million from the prior quarter. The company said orders for workforce housing tied to Data Center projects began this quarter, and it repurchased about $30 million of stock, leaving $158 million of authorization.

Valuation data dated Oct 27, 2026, before the move, showed a market value near $4.09 billion and a 52-week range of $443.34 to $713.01.

3. Regeneron Pharmaceuticals: why are shares surging past their 52-week high?

Regeneron shares are trading up 14.21% at $935.14 after third-quarter revenue rose 36% to $5.1 billion and non-GAAP earnings per share climbed 70% to $20.07. The company also disclosed that Sanofi (NASDAQ:SNY) will pay $1.0 billion upfront for four long-acting antibodies, with up to $7.0 billion in further milestones and costs and profits shared equally.

U.S. net sales of EYLEA HD rose 62% to $699 million, but total U.S. EYLEA Franchise sales were flat at $1.1 billion because the original product declined. Cash and marketable securities were about $18.9 billion.

Market data from Oct 27, 2026 listed a market value near $81.2 billion and a 52-week high of $859.34, a level today's price now exceeds.

4. AutoNation: how did adjusted earnings lift the stock despite lower revenue?

AutoNation shares are trading up 10.73% at $187.51 after third-quarter adjusted earnings per share of $5.11 edged past $5.01 a year earlier. Headline figures were softer: revenue slipped 0.4% to $7.01 billion, Net Income fell 25% to $162.3 million and GAAP diluted earnings per share dropped to $4.87 from $5.65. A smaller share count helped the adjusted gain.

Parts and service Gross Profit reached a record $616.6 million, and AutoNation Finance earned $15.4 million versus $1.5 million a year ago. The board added $1.0 billion to the buyback authorization in October, leaving $1.4 billion available as of Oct 28, 2026.

The release carried no forward guidance. A market value near $5.3 billion, down about 35% over the past year, comes from a snapshot that predates these results.

5. Veralto: why are shares trading higher after a beat on its own guidance?

Veralto shares are trading up 8.97% at $113.39 after third-quarter adjusted earnings of $1.18 per share topped the $1.06 to $1.09 range the company guided in July. Sales rose 7.5% to $1.509 billion, core sales grew 5.1% and adjusted Operating Margin reached 25.6%.

Full-year adjusted earnings guidance was lifted to $4.49 to $4.52 per share from $4.35 to $4.43. The water analytics and product identification company has spent about $1.1 billion on four acquisitions this year and repurchased $550 million of stock.

Valuation figures available date from the July report and include a 52-week high of $110.11, which today's price now exceeds. They are stale, and the exact release timing behind today's move is not confirmed.

Higher-Priced Gainers Compared: Spread, Average and Price Distance

The five gains span a tight range. The average move is 12.60% (calculated from the five reported percentages), and the spread between the largest gain at 14.61% and the smallest at 8.97% is 5.64 percentage points (calculated). The top three sit within 0.40 points of each other (calculated).

Share prices differ far more than the moves. Regeneron at $935.14 trades at roughly 8.25 times the price of Veralto at $113.39 (calculated), so an equal percentage gain is worth very different amounts per share.

The catalysts also differ in quality. FedEx Freight paired revenue growth with raised guidance, Regeneron paired it with a large Partnership payment, Cavco posted record revenue, Veralto topped its own guidance, and AutoNation relied on adjusted earnings and a buyback while revenue slipped. Valuation snapshots for several names predate the move.

What to Watch Next: Guidance Checkpoints and Dated Catalysts

Cavco scheduled its Earnings Call for Oct 30, 2026, where management commentary on input costs and order intake could add detail. FedEx Freight raised guidance for the period ending Dec 31, 2026 and plans to announce a Dividend and share repurchase plan for calendar 2027, subject to board approval.

Regeneron has several dated items: an FDA decision on cemdisiran in generalized myasthenia gravis expected in November 2026, a February 2027 target date for odronextamab, a March 2027 decision on Libtayo and a quarterly dividend payable Dec 3.

AutoNation and Veralto each point to their fourth-quarter reports, though no dates were identified in the source material. Veralto guided fourth-quarter core sales growth of 5.5% to 6.5%, while AutoNation gave no forward guidance.